273 related articles for article (PubMed ID: 19604125)
1. Interleukin-1 beta targeted therapy for type 2 diabetes.
Maedler K; Dharmadhikari G; Schumann DM; Størling J
Expert Opin Biol Ther; 2009 Sep; 9(9):1177-88. PubMed ID: 19604125
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes.
Maedler K; Dharmadhikari G; Schumann DM; Størling J
Handb Exp Pharmacol; 2011; (203):257-78. PubMed ID: 21484575
[TBL] [Abstract][Full Text] [Related]
3. Role of IL-1beta in type 2 diabetes.
Dinarello CA; Donath MY; Mandrup-Poulsen T
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):314-21. PubMed ID: 20588114
[TBL] [Abstract][Full Text] [Related]
4. Macrophages, cytokines and beta-cell death in Type 2 diabetes.
Ehses JA; Böni-Schnetzler M; Faulenbach M; Donath MY
Biochem Soc Trans; 2008 Jun; 36(Pt 3):340-2. PubMed ID: 18481953
[TBL] [Abstract][Full Text] [Related]
5. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
6. Insulitis in type 2 diabetes.
Böni-Schnetzler M; Ehses JA; Faulenbach M; Donath MY
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():201-4. PubMed ID: 18834448
[TBL] [Abstract][Full Text] [Related]
7. Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations or interleukin-1beta.
Börjesson A; Carlsson C
J Endocrinol; 2007 Feb; 192(2):381-7. PubMed ID: 17283238
[TBL] [Abstract][Full Text] [Related]
8. Islet inflammation in type 2 diabetes: from metabolic stress to therapy.
Donath MY; Schumann DM; Faulenbach M; Ellingsgaard H; Perren A; Ehses JA
Diabetes Care; 2008 Feb; 31 Suppl 2():S161-4. PubMed ID: 18227479
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro.
Sommer G; Weise S; Kralisch S; Lossner U; Bluher M; Stumvoll M; Fasshauer M
J Cell Biochem; 2009 Jan; 106(1):103-8. PubMed ID: 19009554
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.
Ehses JA; Ellingsgaard H; Böni-Schnetzler M; Donath MY
Arch Physiol Biochem; 2009 Oct; 115(4):240-7. PubMed ID: 19645635
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production by islets in health and diabetes: cellular origin, regulation and function.
Donath MY; Böni-Schnetzler M; Ellingsgaard H; Halban PA; Ehses JA
Trends Endocrinol Metab; 2010 May; 21(5):261-7. PubMed ID: 20096598
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and insulin resistance.
Kim JH; Bachmann RA; Chen J
Vitam Horm; 2009; 80():613-33. PubMed ID: 19251052
[TBL] [Abstract][Full Text] [Related]
13. Infection-induced inflammatory response of adipocytes in vitro.
Bouwman JJ; Visseren FL; Bouter KP; Diepersloot RJ
Int J Obes (Lond); 2008 Jun; 32(6):892-901. PubMed ID: 18347604
[TBL] [Abstract][Full Text] [Related]
14. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis.
Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN
J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225
[TBL] [Abstract][Full Text] [Related]
15. The inflammasome puts obesity in the danger zone.
Stienstra R; Tack CJ; Kanneganti TD; Joosten LA; Netea MG
Cell Metab; 2012 Jan; 15(1):10-8. PubMed ID: 22225872
[TBL] [Abstract][Full Text] [Related]
16. A clinical perspective of IL-1β as the gatekeeper of inflammation.
Dinarello CA
Eur J Immunol; 2011 May; 41(5):1203-17. PubMed ID: 21523780
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-6 signalling in glucose and lipid metabolism.
Glund S; Krook A
Acta Physiol (Oxf); 2008 Jan; 192(1):37-48. PubMed ID: 18171428
[TBL] [Abstract][Full Text] [Related]
18. Macrophages and islet inflammation in type 2 diabetes.
Eguchi K; Manabe I
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control.
Pedersen BK
Essays Biochem; 2006; 42():105-17. PubMed ID: 17144883
[TBL] [Abstract][Full Text] [Related]
20. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
